2026-2030年全球生物感测器市场

全球生物感测器市场预计在 2025 年至 2030 年间成长至 122.816 亿美元，预测期内复合年增长率为 7.7%。

本报告对全球生物感测器市场进行了全面分析，包括市场规模和预测、趋势、成长要素、挑战以及对约 25 家公司的供应商分析。

本报告对当前市场状况、最新趋势和驱动因素以及整体市场环境进行了最新分析。市场成长的驱动因素包括慢性病和文明病的日益普遍、对即时诊断（POCT）需求的成长、技术进步以及持续的微型化趋势。

本研究客观地结合一手和二手讯息，包括主要行业相关人员的意见，进行了这项研究。报告内容包括对主要企业的分析、全面的市场规模数据、区域細項分析以及供应商格局。报告还包含了历史数据和预测数据。

本研究指出，未来几年全球生物感测器市场成长的关键驱动因素之一是整合数位健康生态系统的发展。此外，多参数、多功能生物感测平台的扩展，以及人们对永续生物感测器设计和环境友善生产方法的日益关注，预计也将产生巨大的市场需求。

目录

第一章执行摘要

第二章 Technavio 分析

• 分析定价、生命週期、顾客购买篮子、采用率和购买标准。
• 输入的重要性及差异化因素
• 混淆因素
• 促进因素和挑战的影响

第三章 市场状况

• 市场生态系统
• 市场特征
• 价值链分析

第四章 市场规模

• 市场的定义
• 市场区隔分析
• 2025年市场规模
• 2025-2030年市场展望

第五章 市场规模与表现

• 2020-2024年全球生物感测器市场
• 2020-2024年产品细分市场分析
• 2020-2024年技术细分市场分析
• 2020-2024年最终用户细分市场分析
• 2020-2024年区域市场分析
• 2020-2024年各国细分市场分析

第六章 定性分析

• 人工智慧的影响：全球生物感测器市场
• 地缘政治衝突影响全球生物感测器市场。

第七章：五力分析

• 五力模型概述
• 买方的议价能力
• 供应商的议价能力
• 新进入者的威胁
• 替代品的威胁
• 竞争威胁
• 市场状况

第八章 市场区隔：依产品

• 比较：按产品
• 穿戴式装置
• 不可穿戴
• 市场机会：依产品划分

第九章 市场区隔：依技术划分

• 比较：按技术
• 电化学
• 光学
• 压电
• 热
• 市场机会：依技术划分

第十章 市场区隔：依最终用户划分

• 比较：按最终用户
• PoC测试
• 居家医疗诊断
• 研究所
• 安全与生物防御
• 食品工业
• 市场机会：依最终用户划分

第十一章 客户情况

第十二章 区域情势

• 区域细分
• 区域比较
• 北美洲
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 荷兰
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 韩国
  • 澳洲
  • 印尼
• 南美洲
  • 巴西
  • 阿根廷
  • 智利
• 中东和非洲
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非
  • 以色列
  • 土耳其
• 市场机会：按地区划分

第十三章 促进因素、挑战与机会

• 市场驱动因素
• 市场挑战
• 促进因素和挑战的影响
• 市场机会

第十四章 竞争格局

• 概述
• 竞争格局
• 混乱局面
• 产业风险

第十五章 竞争分析

• 公司简介
• 公司排名指标
• 企业市场定位
• Abbott Laboratories
• ACON Laboratories Inc.
• Agamatrix Inc.
• Bio Rad Laboratories Inc.
• Biolin Scientific AB
• Conductive Technologies Inc.
• Dexcom Inc.
• F. Hoffmann La Roche Ltd.
• LifeScan IP Holdings LLC
• Medtronic Plc
• Nova Biomedical Corp.
• Sartorius AG
• Sd Biosensor Inc.
• Siemens Healthineers AG
• Xylem Inc.

第十六章附录

The global biosensors market is forecasted to grow by USD 12281.6 mn during 2025-2030, accelerating at a CAGR of 7.7% during the forecast period. The report on the global biosensors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing incidence of chronic and lifestyle-related diseases, escalating demand for point-of-care testing diagnostics, technological advancements and persistent shift towards miniaturization.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global biosensors market is segmented as below:

By Product

• Wearable
• Non-wearable

By Technology

• Electrochemical
• Optical
• Piezoelectric
• Thermal

By End-User

• PoC testing
• Home healthcare diagnostics
• Research laboratories
• Security and bio-defense
• Food industry

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• APAC
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
• South America
  • Brazil
  • Argentina
  • Chile
• Middle East and Africa
  • UAE
  • South Africa
  • Turkey
• Rest of World (ROW)

This study identifies the advancement of integrated digital health ecosystems as one of the prime reasons driving the global biosensors market growth during the next few years. Also, expansion of multiparametric and multifunctional biosensing platforms and increasing emphasis on sustainable biosensor design and eco efficient production practices will lead to sizable demand in the market.

The report on the global biosensors market covers the following areas:

• Global biosensors market sizing
• Global biosensors market forecast
• Global biosensors market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global biosensors market vendors that include Abbott Laboratories, ACON Laboratories Inc., Agamatrix Inc., Ascensia Diabetes Care Holdings AG, Bio Rad Laboratories Inc., Biolin Scientific AB, Conductive Technologies Inc., Cytiva, Dexcom Inc., F. Hoffmann La Roche Ltd., LifeScan IP Holdings LLC, Medtronic Plc, Nova Biomedical Corp., Sartorius AG, Sd Biosensor Inc., Siemens Healthineers AG, Universal Biosensors Group, Xylem Inc., Zimmer and Peacock. Also, the global biosensors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by Technology
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Biosensors Market 2020 - 2024
  • Historic Market Size - Data Table on Global Biosensors Market 2020 - 2024 ($ million)
• 5.2 Product segment analysis 2020 - 2024
  • Historic Market Size - Product Segment 2020 - 2024 ($ million)
• 5.3 Technology segment analysis 2020 - 2024
  • Historic Market Size - Technology Segment 2020 - 2024 ($ million)
• 5.4 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on global biosensors market
• 6.2 Impact of geopolitical conflicts on global biosensors market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Product

• 8.1 Market segments
• 8.2 Comparison by Product
• 8.3 Wearable - Market size and forecast 2025-2030
• 8.4 Non-wearable - Market size and forecast 2025-2030
• 8.5 Market opportunity by Product
  • Market opportunity by Product ($ million)

9 Market Segmentation by Technology

• 9.1 Market segments
• 9.2 Comparison by Technology
• 9.3 Electrochemical - Market size and forecast 2025-2030
• 9.4 Optical - Market size and forecast 2025-2030
• 9.5 Piezoelectric - Market size and forecast 2025-2030
• 9.6 Thermal - Market size and forecast 2025-2030
• 9.7 Market opportunity by Technology
  • Market opportunity by Technology ($ million)

10 Market Segmentation by End-user

• 10.1 Market segments
• 10.2 Comparison by End-user
• 10.3 PoC testing - Market size and forecast 2025-2030
• 10.4 Home healthcare diagnostics - Market size and forecast 2025-2030
• 10.5 Research laboratories - Market size and forecast 2025-2030
• 10.6 Security and bio-defense - Market size and forecast 2025-2030
• 10.7 Food industry - Market size and forecast 2025-2030
• 10.8 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 APAC - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 India - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Australia - Market size and forecast 2025-2030
  • 12.5.6 Indonesia - Market size and forecast 2025-2030
• 12.6 South America - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Argentina - Market size and forecast 2025-2030
  • 12.6.3 Chile - Market size and forecast 2025-2030
• 12.7 Middle East and Africa - Market size and forecast 2025-2030
  • 12.7.1 Saudi Arabia - Market size and forecast 2025-2030
  • 12.7.2 UAE - Market size and forecast 2025-2030
  • 12.7.3 South Africa - Market size and forecast 2025-2030
  • 12.7.4 Israel - Market size and forecast 2025-2030
  • 12.7.5 Turkey - Market size and forecast 2025-2030
• 12.8 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Increasing incidence of chronic and lifestyle-related diseases
  • Escalating demand for point-of-care testing diagnostics
  • Technological advancements and persistent shift towards miniaturization
• 13.2 Market challenges
  • Strict regulatory frameworks and prolonged approval cycles
  • High costs of advanced materials and scalable manufacturing
  • Stability and longevity limitations of biological recognition elements
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Advancement of integrated digital health ecosystems
  • Expansion of multiparametric and multifunctional biosensing platforms
  • Increasing emphasis on sustainable biosensor design and eco efficient production practices

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
  • SWOT
• 15.5 ACON Laboratories Inc.
  • ACON Laboratories Inc. - Overview
  • ACON Laboratories Inc. - Product / Service
  • ACON Laboratories Inc. - Key offerings
  • SWOT
• 15.6 Agamatrix Inc.
  • Agamatrix Inc. - Overview
  • Agamatrix Inc. - Product / Service
  • Agamatrix Inc. - Key offerings
  • SWOT
• 15.7 Bio Rad Laboratories Inc.
  • Bio Rad Laboratories Inc. - Overview
  • Bio Rad Laboratories Inc. - Business segments
  • Bio Rad Laboratories Inc. - Key news
  • Bio Rad Laboratories Inc. - Key offerings
  • Bio Rad Laboratories Inc. - Segment focus
  • SWOT
• 15.8 Biolin Scientific AB
  • Biolin Scientific AB - Overview
  • Biolin Scientific AB - Product / Service
  • Biolin Scientific AB - Key offerings
  • SWOT
• 15.9 Conductive Technologies Inc.
  • Conductive Technologies Inc. - Overview
  • Conductive Technologies Inc. - Product / Service
  • Conductive Technologies Inc. - Key offerings
  • SWOT
• 15.10 Dexcom Inc.
  • Dexcom Inc. - Overview
  • Dexcom Inc. - Product / Service
  • Dexcom Inc. - Key news
  • Dexcom Inc. - Key offerings
  • SWOT
• 15.11 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
  • SWOT
• 15.12 LifeScan IP Holdings LLC
  • LifeScan IP Holdings LLC - Overview
  • LifeScan IP Holdings LLC - Product / Service
  • LifeScan IP Holdings LLC - Key offerings
  • SWOT
• 15.13 Medtronic Plc
  • Medtronic Plc - Overview
  • Medtronic Plc - Business segments
  • Medtronic Plc - Key offerings
  • Medtronic Plc - Segment focus
  • SWOT
• 15.14 Nova Biomedical Corp.
  • Nova Biomedical Corp. - Overview
  • Nova Biomedical Corp. - Product / Service
  • Nova Biomedical Corp. - Key offerings
  • SWOT
• 15.15 Sartorius AG
  • Sartorius AG - Overview
  • Sartorius AG - Business segments
  • Sartorius AG - Key news
  • Sartorius AG - Key offerings
  • Sartorius AG - Segment focus
  • SWOT
• 15.16 Sd Biosensor Inc.
  • Sd Biosensor Inc. - Overview
  • Sd Biosensor Inc. - Product / Service
  • Sd Biosensor Inc. - Key offerings
  • SWOT
• 15.17 Siemens Healthineers AG
  • Siemens Healthineers AG - Overview
  • Siemens Healthineers AG - Business segments
  • Siemens Healthineers AG - Key offerings
  • Siemens Healthineers AG - Segment focus
  • SWOT
• 15.18 Xylem Inc.
  • Xylem Inc. - Overview
  • Xylem Inc. - Business segments
  • Xylem Inc. - Key news
  • Xylem Inc. - Key offerings
  • Xylem Inc. - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations